IRCT20151123025202N35
Not yet recruiting
Phase 1
Investigating the effect of Fampiridine on visual parameters and optic nerve imaging in patients with Anterior Ischemic Optic neuropathy
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with anterior ischemic optic neuropathy
- •Consent to participate in the study
- •At least 3 months have passed since the onset of symptoms
Exclusion Criteria
- •History of seizures
- •Renal failure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluating the short-term effect of Fampridine on cognitive function in Multiple sclerosis patientsIRCT20161212031362N4Iranian Center of Neurological Research108
Recruiting
Phase 3
Fampridine effect on Parkinson disease symptomsParkinson disease.Parkinson's diseaseIRCT20230905059361N1Shahre-kord University of Medical Sciences62
Not yet recruiting
Phase 2
Famotidine for the improvement of cognitive impairments in COVID-19 patientsCOVID-19.COVID-19, virus identifiedU07.1IRCT20090117001556N138Tehran University of Medical Sciences50
Recruiting
Phase 2
Role of Dalfampridine in optic neuritisCTRI/2021/07/034725Department of Health Research
Recruiting
Phase 3
The effect of famotidine on reducing the side effects of prostate cancer radiotherapyIRCT20231121060132N1Kermanshah University of Medical Sciences50